Endogenously produced protein regulators provide feedback signals that regulate the ex vivo expansion of human hematopoietic stem and progenitor cells.
Published: 2004
Language: eng
Number of pages: 188
Description: The absence of effective strategies for the ex vivo expansion of human blood (hematopoietic) stem cells (HSCs) limits the development of many stem cell-based therapies. The focus of this study was to investigate  in vitro processes responsible for regulating HSC proliferation and to utilize this information in the design of a robust methodology for expanding HSCs. Herein we show the existence of a negative feedback control mechanism whereby differentiated blood cells secrete soluble factors that limit HSC expansion. We demonstrate that global culture manipulation strategies including subpopulation selection and media dilution/exchange modulate this feedback mechanism to enable stem cell expansion. Using this approach, we were able to generate increased numbers of long term culture-initiating cells (LTC-ICs; 14.6-fold), rapid non-obese diabetic/severe combined immunodeficient (NOD/SCID) repopulating cells (R-SRCs; 12.1-fold), and long-term NOD/SCID repopulating cells (LT-SRCs; 5.2-fold), compared with input; outputs significantly higher than those obtained in unmanipulated control cultures. In order to enable this culture methodology for therapeutic applications, a closed-system bioprocess was designed which incorporated in-line subpopulation selection and media dilution/exchange processes. Experiments showed that the bioprocess was able to expand colony forming cells (CFCs), LTC-ICs and LT-SRCs in a manner consistent with results using standard tissue culture dishes. Studies to optimize the bioprocess operating conditions were also performed. In these studies it was found that non-specific cell loss, which occurred during the subpopulation selection step, could be decreased by increasing flow rate through the selection element. The ability to decrease cell loss is important since it should facilitate higher expansions of hematopoietic stem and progenitor cells within the bioprocess. Furthermore, optimization of the subpopulation selection process through the identification of specific inhibitory factor secreting cells may further augment the measured expansions. To initiate this goal, the gel microdrop (GMD) assay was developed as a means to measure protein secretion from individual cells in the context of cell surface phenotype. The development and use of the GMD assay represents the first step in the design of a second generation bioprocess which should have an even greater capacity for the ex vivo expansion of HSCs.
Notes: Adviser:  Peter Zandstra.

Thesis (Ph.D.)--University of Toronto, 2004.

Electronic version licensed for access by U. of T. users.

Source: Dissertation Abstracts International, Volume: 65-10, Section: B, page: 5258.